What does DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE do?

DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE is a specialist medical practice in Lokeren. Private Limited, started on 13 March 2001, 1 establishment.

What is the address of DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE?

The registered office of DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE is located at Molsbergenstraat 6, 9160 Lokeren.

Is DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE still active?

Yes. According to the CBE (15 November 2026) DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE is active, legal situation “Normale toestand”, started on 13 March 2001.

Is DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE registered on Peppol?

Yes, DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE is registered on the Peppol network with ID 0208:0474305353.

What is the enterprise number of DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE?

The enterprise number of DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE is BE0474305353.

When was DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE founded?

DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE was founded on 13 March 2001.

Is DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 March 2001; 5 annual accounts filed, latest fiscal year 2025.

How much profit did DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE make in 2025?

DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE posted a profit after taxes of € 566,625 in financial year 2025.

What is the revenue of DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE?

As a small company, DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 880,591.

DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE (Private Limited)

Dossier DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE, printed on 15 November 2026 from databakkes.be/en/0474305353/dr-mels-f-medische-beeldvorming-radiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE from Lokeren, company number BE0474305353, closed financial year 2025 with a result of € 566,625 after tax. For that financial year DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE recorded a gross margin of € 880,591 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € 539,258 to € 566,625. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 1.8 million

▲ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 566,625

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 239,736

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.8 million.

People and assets in 2025

Vehicles and equipment

€ 131,302

▲ 202% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go

€ 71,293

▼ 34% vs 2024

€ 36,936 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 5,820

▲ 130% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 144,032

▲ 19% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 318,240 Gross margin 2022: € 318,240 First fiscal year in the series	€ 648,682 Gross margin 2023: € 648,682 ▲ 104% vs 2022 (€ 318,240) Favourable step	€ 844,897 Gross margin 2024: € 844,897 ▲ 30% vs 2023 (€ 648,682) Favourable step	€ 880,591 Gross margin 2025: € 880,591 ▲ 4% vs 2024 (€ 844,897) Favourable step	▲ 4%
Profit after taxes	€ 176,737 Profit after taxes 2022: € 176,737 First fiscal year in the series	€ 398,507 Profit after taxes 2023: € 398,507 ▲ 125% vs 2022 (€ 176,737) Favourable step	€ 539,258 Profit after taxes 2024: € 539,258 ▲ 35% vs 2023 (€ 398,507) Favourable step	€ 566,625 Profit after taxes 2025: € 566,625 ▲ 5% vs 2024 (€ 539,258) Favourable step	▲ 5%
Equity	€ 450,392 Equity 2022: € 450,392 First fiscal year in the series	€ 786,391 Equity 2023: € 786,391 ▲ 75% vs 2022 (€ 450,392) Favourable step	€ 1,270,953 Equity 2024: € 1,270,953 ▲ 62% vs 2023 (€ 786,391) Favourable step	€ 1,837,578 Equity 2025: € 1,837,578 ▲ 45% vs 2024 (€ 1,270,953) Favourable step	▲ 45%
Total debts	€ 472,626 Total debts 2022: € 472,626 First fiscal year in the series	€ 454,997 Total debts 2023: € 454,997 ▼ 4% vs 2022 (€ 472,626) Favourable step	€ 505,881 Total debts 2024: € 505,881 ▲ 11% vs 2023 (€ 454,997) Unfavourable step	€ 376,877 Total debts 2025: € 376,877 ▼ 26% vs 2024 (€ 505,881) Favourable step	▼ 26%
Cash	€ 169,014 Cash 2022: € 169,014 First fiscal year in the series	€ 390,057 Cash 2023: € 390,057 ▲ 131% vs 2022 (€ 169,014) Favourable step	€ 254,309 Cash 2024: € 254,309 ▼ 35% vs 2023 (€ 390,057) Unfavourable step	€ 239,736 Cash 2025: € 239,736 ▼ 6% vs 2024 (€ 254,309) Unfavourable step	▼ 6%
Land & buildings	€ 398,469 Land & buildings 2022: € 398,469 First fiscal year in the series	€ 388,205 Land & buildings 2023: € 388,205 ▼ 3% vs 2022 (€ 398,469) Unchanged	€ 377,942 Land & buildings 2024: € 377,942 ▼ 3% vs 2023 (€ 388,205) Unchanged	€ 367,679 Land & buildings 2025: € 367,679 ▼ 3% vs 2024 (€ 377,942) Unchanged	▼ 3%
Retained profit	€ 425,392 Retained profit 2022: € 425,392 First fiscal year in the series	€ 761,391 Retained profit 2023: € 761,391 ▲ 79% vs 2022 (€ 425,392) Favourable step	€ 1,245,953 Retained profit 2024: € 1,245,953 ▲ 64% vs 2023 (€ 761,391) Favourable step	€ 1,812,578 Retained profit 2025: € 1,812,578 ▲ 45% vs 2024 (€ 1,245,953) Favourable step	▲ 45%
Dividend	€ 28,028 Dividend 2022: € 28,028 First fiscal year in the series	€ 62,508 Dividend 2023: € 62,508 ▲ 123% vs 2022 (€ 28,028) Unchanged	€ 54,695 Dividend 2024: € 54,695 ▼ 12% vs 2023 (€ 62,508) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 54,695) Unchanged	▼ 100%
Bank debt	€ 192,806 Bank debt 2022: € 192,806 First fiscal year in the series	€ 143,491 Bank debt 2023: € 143,491 ▼ 26% vs 2022 (€ 192,806) Favourable step	€ 107,668 Bank debt 2024: € 107,668 ▼ 25% vs 2023 (€ 143,491) Favourable step	€ 71,293 Bank debt 2025: € 71,293 ▼ 34% vs 2024 (€ 107,668) Favourable step	▼ 34%
Balance sheet total	€ 923,018 Balance sheet total 2022: € 923,018 First fiscal year in the series	€ 1,241,387 Balance sheet total 2023: € 1,241,387 ▲ 34% vs 2022 (€ 923,018) Unchanged	€ 1,776,835 Balance sheet total 2024: € 1,776,835 ▲ 43% vs 2023 (€ 1,241,387) Unchanged	€ 2,214,455 Balance sheet total 2025: € 2,214,455 ▲ 25% vs 2024 (€ 1,776,835) Unchanged	▲ 25%

By gross margin, DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE ranks 2nd of 16 companies with main activity “Activiteiten van medisch specialisten” in Lokeren that publish figures (fiscal year 2025).

Key figures of DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE?

What happened at DR. MELS F. MEDISCHE BEELDVORMING & RADIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 566,625 (▲ 5% vs 2024). Source: NBB ↗
Mar 13, 2001 Start of the company according to the CBE. KBO
Feb 28, 2001 New establishment in Lokeren. KBO